TFPI APX2009 : The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells 4SC-202 : 4sc-202 and Ink-128 cooperate to reverse the epithelial to mesenchymal transition in OSCC